MYD88 and lymphoma: We found that the hMyD88Δ1-148L265P fragment indeed exhibited constitutive activity in the presence of full length MyD88 (Figure 7E); thus revealing that the lymphoma cells harboring the L265P mutation are able to evade the caspase-mediated negative feedback regulation of the MyD88-mediated inflammatory signaling pathway.